Background Quality of life (QOL) measures are an important patient-relevant outcome measure for clinical studies. Currently there is no fully validated cough-specific QOL measure for paediatrics. The objective of this study was to validate a cough-specific QOL questionnaire for paediatric use.
Method 43 children (28 males, 15 females; median age 29 months, IQR 20–41 months) newly referred for chronic cough participated. One parent of each child completed the 27-item Parent Cough-Specific QOL questionnaire (PC-QOL), and the generic child (Pediatric QOL Inventory 4.0 (PedsQL)) and parent QOL questionnaires (SF-12) and two cough-related measures (visual analogue score and verbal category descriptive score) on two occasions separated by 2–3 weeks. Cough counts were also objectively measured on both occasions.
Results Internal consistency for both the domains and total PC-QOL at both test times was excellent (Cronbach alpha range 0.70–0.97). Evidence for repeatability and criterion validity was established, with significant correlations over time and significant relationships with the cough measures. The PC-QOL was sensitive to change across the test times and these changes were significantly related to changes in cough measures (PC-QOL with: verbal category descriptive score, rs=−0.37, p=0.016; visual analogue score, rs=−0.47, p=0.003). Significant correlations of the difference scores for the social domain of the PC-QOL and the domain and total scores of the PedsQL were also noted (rs=0.46, p=0.034).
Conclusion The PC-QOL is a reliable and valid outcome measure that assesses QOL related to childhood cough at a given time point and measures changes in cough-specific QOL over time.
- Quality of life
- paediatric cough
- clinical impact
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Cough is the most common symptom of respiratory illness, and the majority of children with isolated chronic cough do not have asthma.1 2 It is thus not surprising that cough is a commonly used outcome measure in research and clinical studies.3–5 Chronic cough is related to a variety of aetiologies6 and may not be categorised into a specific disease process rendering quality of life (QOL) measures for respiratory diseases such as that for asthma unsuitable substitutes for cough research. Disease-specific QOL inventories have been shown to be significantly superior to generic QOL inventories,7 with cough-specific QOL measures for adults8 9 showing specificity and sensitivity over generic QOL measures. The inclusion of factors such as urinary incontinence in these adult cough QOL questionnaires, however, makes them clearly inappropriate for paediatrics. Furthermore the importance and relevance of paediatric-specific QOL instruments has been increasingly recognised.10–12 The adult cough-specific QOL questionnaires,8 9 13 however, highlighted the need for a cough-specific QOL measure and demonstrated the poor appreciation by physicians of the impact of chronic cough on their patients.8 9 Our previous studies have confirmed the high burden of parental concern in children with chronic cough.14 15 We have also shown that our preliminary QOL questionnaire derived from a clinical impact method was internally consistent and valid.15
As young children are unable to verbally express themselves adequately, it is standard practice for parents to be proxy assessors of their young child's medical condition.16 Also, parents/carers are themselves affected by their child's medical condition and thus the parents' own QOL is relevant. Thus, QOL measures used in paediatrics concern the parents/carers themselves (such as in the Short Form Health Survey, SF-1217) or are proxy QOL measures (ie, parental perception of their child's illness; eg, Pediatric QOL Inventory 4.0 (PedsQL)18). A third type of QOL measure for use with children combines both, whereby the items include both parental-proxy and parent's QOL measures such as in Juniper's widely used child asthma QOL questionnaire for carers.16
Valid and clinically relevant outcome measures are essential for clinical research. Current outcome measures for paediatric cough are limited.2 Indeed we described the first validated paediatric subjective cough system.19 The limitations of subjective cough symptom reporting as an isolated symptom has led to groups emphasising the necessity for objective monitoring of cough.20 Ambulatory objective cough monitoring systems21 that record the number of coughs are available but are limited to research.4 The relationships between subjective and objective determinants of cough in children are modest, and the choice of the cough indices depends on the reason for performing the measurement.4 Thus, although objective cough measurement is the ‘gold standard’, it is arguably not patient-relevant, necessitating a cough-specific QOL questionnaire as a patient-relevant outcome measure.
There is currently no fully validated cough QOL questionnaire for paediatric use. In this study we aimed to validate our Parent Cough-Specific QOL questionnaire (PC-QOL)15 by comparing the questionnaire derived from the clinical impact method with objective and subjective paediatric cough measures as well as with generic QOL measures. The sensitivity of the PC-QOL to change over time will also be contrasted to changes in cough measures.
Children aged <14 years newly referred with chronic cough (>4 weeks6) to the Royal Children's Hospital, Brisbane were eligible. All had a medical intervention that consisted of a consultation and a variety of investigations and treatments depending on the child's clinical history and examination.6 Exclusion criteria were: presence of previously diagnosed respiratory diseases (eg, cystic fibrosis), classical asthma (recurrent wheeze or dyspnoea responsive to β2-agonist) or other underlying disorders such as neurodevelopmental or congenital heart disease. Written consent was obtained from parents and the study was approved by the hospital's human ethics committee.
At initial appointment (Time-1, T1), each parent completed the PC-QOL along with two measures aimed to quantify the chronicity of their child's cough—a cough visual analogue scale (cough VAS)19 and a cough verbal category descriptive scale (cough VCD).19 The PC-QOL was interviewer administered. Additionally parents completed the PedsQL18 and SF-12.17 Clinical data were collected on a standardised sheet and parents were given cough diary cards (VAS and VCD) which they completed at home. A digital voice recorder was attached to the child using a lanyard. At a follow-up visit (Time-2, T2) 2–3 weeks postinitial visit, parents repeated all the questionnaires, and ambulatory cough monitoring was re-recorded.
For the cough VAS, parents rated how troublesome their child's cough was on a 10-point scale from 1=no trouble to 10=troublesome all the time. Child's severity of cough (VCD) was rated on a 6-point scale (0=no cough to 5=severe cough and cannot perform activities), with increasing scores reflecting greater interference with usual activities. This rating (a cough scoring diary) has been validated previously against an objective cough meter measure, and changes in this subjective cough rating have been shown to reflect changes in cough counts.19 The digital voice recorder (Sony PCP330F, Japan) recorded continuously for 24 h. The wav file was downloaded, coded and replayed whereby the cough counts (number of coughs) were manually counted by a person blind to all the child's data. As some children did not have 24 h of recording, cough counts were analysed as number of coughs per hour.
The PC-QOL is a 27-item questionnaire designed to assess the level of frequency of parents' feelings (15 items) and worry (12 items) related to their child's cough. It uses a 7-point Likert-type scale, with higher scores reflecting lower frequency and fewer worry concerns (ie, greater QOL). Previous research15 indicates that this ‘clinical impact’-derived PC-QOL is both reliable and valid.
The SF-12 v217
The SF-12 is a measure of health functioning that computes to eight subscales and two summary scales (Physical Component Summary and Mental Component Summary), with higher scores reflecting better health states.
This generic multidimensional questionnaire is designed for parental reports of their child's QOL. It has separate versions for each of four age groups (2–4, 5–7, 8–12 and 13–18 years) and has been used to validate disease-specific and symptom-specific QOL.16 The 23 items are responded to on a 5-point Likert-type scale (0=never a problem to 4=almost always a problem) and load on to four dimensions of ‘functioning’ (Physical, Emotional, Social and School Functioning). These can then be grouped into three summary scores (Psychosocial Health, Physical Health and Total). Items were reverse-scored so that higher scores reflected more positive functioning.
The clinical impact-derived PC-QOL15 formed the basis of the following analyses. The 27-item instrument was first subjected to domain allocation. The domains—psychological, physical and social—were based on the WHO definition of health,22 and expert opinion from respiratory paediatricians and mental health professionals. Allocation of items to domains followed a two-step procedure: each item's face validity as determined by the expert panel and each item's correlation with the domain score.
Psychometric properties of reliability (internal consistency–Cronbach's alpha, test–retest and consistency–intraclass correlations) and validity (criterion) were examined for the full scale and for each of the domains (see supplementary file online). Further analyses were conducted to determine whether the instrument was sensitive to change over time following medical interventions. Non-parametric analyses (Spearman correlations, Mann–Whitney U test and Wilcoxon signed ranked test) are reported throughout as statistical assumptions essential for parametric analyses were violated (eg, non-normal distributions). Effect sizes are also included. These measure the relative strength of the relationship for the tests of differences in scores across T1 and T2 and quantify the size of this difference over time as a standardised, scale-free measure. Inspection of bivariate scatterplots revealed a number of statistical outliers (see supplementary file). These cases (n=7) depicted an unusual relationship between PC-QOL scores and cough counts/h, and were thus removed from those analyses. Data were analysed using SPSS software v17 (SPSS, Chicago, Illinois, USA).
Forty-three children (28 males, 15 females; median age 29 months, IQR 20–41 months) and a parent of each child participated in this study. Protracted bacterial bronchitis was diagnosed in 30 children (69.8%), bronchiectasis in 6 (14%), asthma in 6 (14%) and tracheomalacia in 1 (2.2%). Preliminary analyses revealed that PC-QOL total and domain scores did not differ at either T1 or T2 for the participants with protracted bacterial bronchitis compared with those with other chronic respiratory conditions, Mann–Whitney U tests, all Z scores ≤1.18, all p values ≥0.239. The data across the differing conditions could thus be reliably combined.
The allocation of items to domains identified 11 items in each of the psychological and physical domains and 5 items in the social domain. Cronbach alphas for each of the domains were high (at T1, α range=0.70–0.90; at T2, α range=0.86–0.95) and correlations of items with their domains were significant (at T1, range=0.32–0.81; at T2, range=0.53–0.88). Cronbach alphas for the full-scale PC-QOL at T1 (α=0.94) and T2 (α=0.97) were both excellent. Test–retest reliability analyses revealed intraclass correlations for the domains of the PC-QOL and the full scale to be high and significant, ranging from 0.40 to 0.51, all p values ≤0.004. Intraclass correlations for the cough measures were significant for both cough counts/h (rs=0.43, p<0.003) and cough VAS (rs=0.36, p=0.013), but not for cough VCD (rs=0.20, p=0.100).
Evidence for criterion validity was examined through the relationships between scores on the PC-QOL and the cough measures. The correlations for T1 and T2 are presented in table 1 and, for the most part, support criterion validity. There were significant correlations for the domains and total PC-QOL and VCD and VAS across all measures and time points and for the cough counts/h at postinitial visit for the social domain and total score. The correlations of the PC-QOL with SF-12 and PedsQL revealed some significant and some high absolute relationships especially with the total component score of the SF-12 at T2 and the physical summary and total scores of the PedsQL. A low completion rate of the PedsQL (n=23) is a likely explanation for the few significant correlations despite satisfactory absolute values. This low completion rate was due to an administrative error and not reflected in the completion of other instruments.
Evidence was also gained by examining the correlations between the difference scores—that is, whether the difference score in PC-QOL across the two test times was related to difference scores in the cough measures. Total PC-QOL correlated significantly with cough VCD score (rs=−0.55, p=0.001) and cough VAS (rs=−0.55, p=0.001), with a trend to significance for cough counts/h (rs=−0.32, p=0.074). Significant correlations of the difference scores for the social domain of PC-QOL and the domains and total PedsQL were also noted, rs≥0.46, p≤0.034. Further, the PC-QOL was, as were the cough measures, sensitive to change over time, Wilcoxon ranked sign tests, Z scores ≥3.01, p values ≤0.003. The means for each measure across time are presented in figure 1. The effect sizes for change in domain and total PC-QOL scores and cough measures are presented in table 2.
We validated our PC-QOL derived from the clinical impact method by comparing PC-QOL with other measures of cough severity (subjective cough scores, objective cough counts) and generic QOLs (PedsQL and SF-12) across two time frames in 43 newly referred children with chronic cough. We found that the PC-QOL demonstrated high levels of both internal consistency and test–retest consistency—that is, the items all reliably loaded on a single construct of paediatric cough-related QOL and measurement of this construct was consistent over a 2–3 week period. High internal consistencies for the full-scale PC-QOL may represent possible redundancy of items; however, closer inspection revealed that all items added significantly to the construct in terms of both face validity and statistical estimates. Criterion validity of the PC-QOL was endorsed, with significant correlations of domains and total scores with the component and summary scores of the SF-12 and PedsQL. We also found that PC-QOL scores were sensitive to change over time, and mirrored the changes in other cough severity measures (subjective and objective). The findings from the present study endorse the 27-item PC-QOL as a cough-specific QOL measure that is reliable and valid.
Adult cough-specific QOL questionnaires have been used for several years.8 9 Similar to the Leicester Cough Questionnaire,9 our PC-QOL covers three domains highlighted by the WHO definition of health, was derived from a larger pool of items by the clinical impact method16 and was validated against measures of generic QOL measures. An important difference, however, is that we have determined the PC-QOL validity against both objective (cough counts) and subjective (VCD, VAS) measures of cough severity. Our questionnaire is also longer (27 items compared with 19 items) but covers both worry and frequency of parent's concerns for the effect of their child's chronic cough. Compared with the Cough Quality of Life Questionnaire,8 the PC-QOL is of similar length but covers fewer domains. Although the Cough Quality of Life Questionnaire demonstrated strong internal and test–retest reliability, information about its criterion validity and its sensitivity to change over time was not reported.8
In this study we present the first validated cough-specific QOL questionnaire for paediatric use. It has corroborated our previous findings15 of high reliability and strong validity in an instrument designed to identify and locate areas of concern for parents and carers of children with chronic cough. Validity was confirmed, with strong relationships across two time points to both subjective cough measures and objective cough counts. The support for the measure was further enhanced by the significant comparisons with a previously validated measure of generic adult QOL (SF-12) and a generic multidimensional paediatric QOL (PedsQL) instrument. In the validation process, it is important to show that a measure can be sensitive to change and that this sensitivity emulates changes in correspondingly validated measures. Our instrument was able to detect changes in QOL following a clinical intervention over 2–3 weeks and these changes were associated with observed changes in cough measures and counts, as well as changes in PedsQL.
The item stems in our PC-QOL capture frequency and worry about aspects of child and family functioning affected by a child's chronic cough. This is similar to the widely used asthma PQLQ developed by Juniper et al.16 The items in our PC-QOL can be reliably partitioned into the domains of psychological, social and physical concerns, as well as a total measure of QOL. The WHO domains of psychological, physical and social functioning were confirmed through face validity supported by expert opinion. The domains were also shown to be sensitive to change following clinical intervention.
One limitation of the present study was the relatively short time period between testing times. A longer time interval would enable a more thorough examination of the sensitivity of the instrument to detect change. Although there were some significant correlations to the SF-12 and PedsQL at both testing times and across time, these were not consistent. It may be that the PC-QOL and its domains are measuring slightly different aspects of functioning compared with the SF-12 and PedsQL. SF-12 specifically assesses the parent's QOL (as opposed to the child's) and PedsQL draws on more generalised functioning (as opposed to specific illness related). Thus further research in this area is warranted as the relatively small sample sizes for some of the analyses limits the generalisability of the results. Also, in the present study, the items were researcher administered for greater control. However, we believe that the PC-QOL can be self-administered and, under these conditions, would take 10–15 min to complete. An extension of a children-specific cough QOL questionnaire that is child completed is also required. Also, the minimal important difference for our PC-QOL is yet to be determined.
The clinical utility of the PC-QOL is readily apparent as an outcome measure for evaluating interventions in clinical research involving children with cough. Furthermore, its impact can stretch to identifying foci for non-medical interventions to accompany medical interventions. In this regard, it can provide insight into the impact of treatment across aspects of life that may be related to a child's chronic cough condition but can sometimes be ignored due to a focus on the illness component of treatment. In particular, the PC-QOL can assist in identifying potential psychological, social and physical areas requiring assistance. It may also be particularly useful to assist clinicians in assessing whether clinical interventions have a significant and positive impact on both physical and psychosocial functioning over time.
The PC-QOL can be completed quickly and easily by parents, and could be included as part of the baseline assessment of patients as well as for evaluation and monitoring of treatment for cough-dominant conditions. The strong psychometric features of the measure and its significant correlation with other QOL measures and subjective and objective measures of cough support its robustness as a valid outcome measure. The performance of PC-QOL further reinforces the importance and relevance of paediatric-specific QOL instruments for this population.10–12
We thank the parents and children who participated in the study. We also thank Drs Masters, Francis and Dore for allowing their patients to participate in the study.
Funding The study was supported by a Royal Children's Hospital Foundation Grant (Brisbane, Australia). AC is supported by an NHMRC Practitioner Fellowship (Grant #545216).
Competing interests None.
Ethics approval This study was conducted with the approval of the Royal Children's Hospital Human Ethics Committee, Brisbane, Australia.
Provenance and peer review Not commissioned; externally peer reviewed.